SARS-CoV-2 Point Mutation and Deletion Spectra and Their Association with Different Disease Outcomes

Authors:

Abstract
The study shows that mutant spectra of SARS-CoV-2 from diagnostic samples differ in point mutation abundance and complexity and that significantly larger values were observed in virus from patients who developed mild COVID-19 symptoms. Mutant spectrum complexity is not a uniform trait among isolates. The nature and location of low-frequency amino acid substitutions present in mutant spectra anticipate great potential for phenotypic diversification of SARS-CoV-2.
All Related Versions
Funding Information
  • MEC | Instituto de Salud Carlos III (COV20/00181, PI18/00210, PI21/00139, CPII19/00001)
  • MEC | Consejo Superior de Investigaciones Científicas (CSIC-COV19-014)
  • Fundació la Marató de TV3 (525/C/2021)
  • Ministerio de Ciencia e Innovación (PID2020-113888RB-I00)
  • Ministerio de Ciencia, Innovación y Universidades (BFU2017-91384-EXP)
  • Comunidad de Madrid (S2018/BAA-4370)
  • Instituto de Salud Carlos III (CPII17/00006)
  • MEC | Instituto de Salud Carlos III (CP16/00116)
  • MEC | Instituto de Salud Carlos III (FI19/00119)
  • Comunidad de Madrid (PEJD-2019-PRE/BMD-16414)
  • Ministerio de Ciencia, Innovación y Universidades (PRE2018-083422)
  • Ministerio de Asuntos Económicos y Transformación Digital, Gobierno de España (DI-17-09134)

This publication has 89 references indexed in Scilit: